CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Total operating expenses	$ 32,657	$ 16,184
Loss from operations	(32,657)	(16,184)
Other income (expense):
Other income, net	1,490	21
Change in fair value of preferred stock tranche rights		(50)
Change in fair value of anti-dilution right		(30)
Total other income (expense), net	1,490	(59)
Net loss	$ (31,167)	$ (16,243)
Net loss per share—basic	$ (7.56)	$ (9.32)
Net loss per share—diluted	$ (7.56)	$ (9.32)
Weighted-average common stock outstanding—basic	4,121,912	1,743,382
Weighted-average common stock outstanding—diluted	4,121,912	1,743,382
Comprehensive loss:
Net loss	$ (31,167)	$ (16,243)
Other comprehensive loss:
Unrealized loss on available-for-sale investments	(95)
Comprehensive loss	(31,262)	(16,243)
Research and Development
Operating expenses:
Total operating expenses	23,949	13,718
General and Administrative
Operating expenses:
Total operating expenses	$ 8,708	$ 2,466